Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001567619-20-013202

Options or other derivatives

  • 10% owner bought 22,727 shares at $880.00 ($19,999,760)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · 10% owner

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-07-09 Purchase : show line 1 in the form Series A Convertible Preferred Stock +3,692 $880.00 $3,248,960 11,914 I
2020-07-09 Purchase : show line 2 in the form Series A Convertible Preferred Stock +19,035 $880.00 $16,750,800 55,500 I
Loading xslF345X03/doc1.xml…